- Home
- PPSI vs ICCM Comparison
PPSI vs ICCM Comparison
Compare PPSI & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PPSI | ICCM |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Electrical Products | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.4M | 43.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PPSI | ICCM |
|---|---|---|
| Price | $4.04 | $0.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $12.00 | $2.50 |
| AVG Volume (30 Days) | 149.4K | ★ 204.3K |
| Earning Date | 11-13-2025 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.86 | N/A |
| Revenue | ★ $31,751,000.00 | $2,975,000.00 |
| Revenue This Year | $26.84 | $19.87 |
| Revenue Next Year | $10.26 | $31.38 |
| P/E Ratio | $1.43 | ★ N/A |
| Revenue Growth | ★ 105.82 | N/A |
| 52 Week Low | $2.25 | $0.54 |
| 52 Week High | $5.70 | $1.66 |
Technical Indicators
Market Signals| Indicator | PPSI | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 38.66 | 36.80 |
| Support Level | $3.87 | $0.59 |
| Resistance Level | $4.48 | $0.62 |
| Average True Range (ATR) | 0.32 | 0.03 |
| MACD | -0.07 | -0.00 |
| Stochastic Oscillator | 5.05 | 25.90 |
Price Performance
Historical ComparisonAbout PPSI Pioneer Power Solutions Inc.
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.